glp-1 drugs and depression GLP-1s associated with reduced risk for depression, anxiety in patients with diabetes Part 2 of a 3-Part
Description
Carvalho, T
The Era of Small-Molecule GLP-1 Drugs Is Emerging The approval of Orforglipron represents more than the launch of a new drugit reflects a major shift in oral GLP-1 drug development trends toward small-molecule innovation
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, et al
10.1016/j.peptides.2017.12.013 66 JrgensenN
